BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15958317)

  • 1. [Association of S100A4 mRNA expression with differentiation and metastasis of renal cell carcinoma].
    Zhou HK; Zhao YB; Zheng SB; Chen T; Mao XM; Qi H; Wu RJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):712-4, 717. PubMed ID: 15958317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
    Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
    J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
    Li HJ; Chen YX; Wang Q; Zhang YG
    Eur Rev Med Pharmacol Sci; 2014; 18(6):817-27. PubMed ID: 24706305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of S100A4 in renal epithelial neoplasms.
    Wang LJ; Matoso A; Sciandra KT; Yakirevich E; Sabo E; Zhang Y; Meitner PA; Tavares R; Noble L; Pareek G; DeLellis RA; Resnick MB
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):71-6. PubMed ID: 21691200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
    Waalkes S; Eggers H; Blasig H; Atschekzei F; Kramer MW; Hennenlotter J; Tränkenschuh W; Stenzl A; Serth J; Schrader AJ; Kuczyk MA; Merseburger AS
    Biomark Med; 2011 Apr; 5(2):219-25. PubMed ID: 21473727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
    Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
    Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma.
    Chong HI; Lee JH; Yoon MS; Suh DS; Kim K; Kim JY; Choi KU
    Oncol Rep; 2014 Jun; 31(6):2701-7. PubMed ID: 24756855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of Bmi-1 mRNA expression with differentiation, metastasis and prognosis of gastric carcinoma].
    Huang KH; Liu JH; Li XX; Song LB; Zeng MS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):973-5. PubMed ID: 17666329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.
    Waalkes S; Atschekzei F; Kramer MW; Hennenlotter J; Vetter G; Becker JU; Stenzl A; Merseburger AS; Schrader AJ; Kuczyk MA; Serth J
    BMC Cancer; 2010 Sep; 10():503. PubMed ID: 20860816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell Carcinoma.
    Sugiyama T; Ozono S; Miyake H
    Anticancer Res; 2020 Nov; 40(11):6337-6343. PubMed ID: 33109571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
    Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
    Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma.
    Domoto T; Miyama Y; Suzuki H; Teratani T; Arai K; Sugiyama T; Takayama T; Mugiya S; Ozono S; Nozawa R
    Cancer Sci; 2007 Jan; 98(1):77-82. PubMed ID: 17083565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.
    Yuan J; Takahashi A; Masumori N; Itoh N; Tsukamoto T
    Int J Urol; 2006 Mar; 13(3):265-70. PubMed ID: 16643621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of P27kip1 in renal cell carcinoma and its clinical significance].
    Wu P; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1883-6, 1889. PubMed ID: 20813693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced gene expression of bikunin as a prognostic marker for renal cell carcinoma.
    Bayraktar E; Igci M; Erturhan S; Igci YZ; Karakok M; Gogebakan B; Ulasli M; Cakmak EA; Arslan A
    Exp Oncol; 2014 Jun; 36(2):107-11. PubMed ID: 24980765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.